risankizumab,tofacitinib,upadacitinib,infliximab
pfizer,abbvie,boehringer ingelheim,janssen
['risan', ' upa ', ' uc ', 'tofa']
many excellent abstracts. some highlights:
1. subq ifx is coming and is effective. 2. risankizumab can take 6 months for response/remission - dubinsky
3. upa works in tofa failure in uc . can be fast or slow in cd.
GI with focus on IBD, EOE, C.dif, CRCS @CapDigestive in MD. Proud dad 👨‍👧. @MountSinaiGI, @BIDMC_IM, @GWSMHS, @theNCI, @StMarysMD. Retweets ≠ endorsement.